- Research works
- 86 ▲ 18% vs 2013–17
- Citations
- 1.5k 17.1 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 25% world 28%
Not ranked overall: Bristol-Myers Squibb (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 10.3×. Every wedge is a field page.
Which keywords describe research at Bristol-Myers Squibb (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Synthesis, Enantioselective Synthesis, Chemotherapy, Biological Evaluation, Anticancer Agents, Parastomal Hernia and Stoma Complications.
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Neurotoxicity
- Metal-Catalyzed Reactions
- HIV Infection
- Catalytic
- Tumor Microenvironment
- Treatment Guidelines
- Organocatalysis
- Drug Resistance
- Health Utility Measures
- Clinical Practice Guidelines
- Antiretroviral Therapy
- Clinical Trials
- Asymmetric Synthesis
- Asymmetric Catalysis
- Stoma Complications
- Anticancer Agents
- Enantioselective Synthesis
- Synthesis
- Quality of Life
- Chemotherapy
- Biological Evaluation
- Parastomal Hernia
- Medicinal Chemistry
- Stereocontrolled Synthesis
- Transition Metal Catalysis
- Targeted Therapy
- C-C Bond Formation
- Cost-effectiveness Analysis
- Drug Discovery
- Enantioselective Reactions
- Prognostic Factors
- Antimicrobial Resistance
- Amination
- Organometallic Chemistry
- Hepatotoxicity
- Genomic Profiling
- ALK Inhibitors
- EGFR Mutations
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life10▲ 8.5×8 topics
- Synthesis8▲ 17×12 topics
- Chemotherapy5▲ 8.5×13 topics
- Enantioselective Synthesis5▲ 37×3 topics
- Biological Evaluation5▲ 48×6 topics
- Anticancer Agents4▲ 20×4 topics
- Parastomal Hernia4▲ 467×1 topic
- Stoma Complications4▲ 467×1 topic
- Medicinal Chemistry4▲ 11×5 topics
- Asymmetric Catalysis3▲ 61×1 topic
- Stereocontrolled Synthesis3▲ 613×1 topic
- Asymmetric Synthesis3▲ 25×3 topics
- Transition Metal Catalysis3▲ 26×3 topics
- Clinical Trials3▲ 5.7×6 topics
- Targeted Therapy3▲ 15×4 topics
- Antiretroviral Therapy3▲ 14×5 topics
- C-C Bond Formation3▲ 35×2 topics
- Clinical Practice Guidelines2▲ 5.2×8 topics
- Cost-effectiveness Analysis2▲ 38×1 topic
- Health Utility Measures2▲ 38×1 topic
- Drug Discovery2▲ 6.8×6 topics
- Drug Resistance2▲ 8.5×5 topics
- Enantioselective Reactions2▲ 28×1 topic
- Organocatalysis2▲ 38×1 topic
- Prognostic Factors2▲ 5.7×5 topics
- Treatment Guidelines2▲ 12×3 topics
- Antimicrobial Resistance2▲ 9.4×3 topics
- Tumor Microenvironment2▲ 6.8×4 topics
- Amination2▲ 82×1 topic
- Catalytic2▲ 16×1 topic
- Organometallic Chemistry2▲ 16×3 topics
- HIV Infection2▲ 18×3 topics
- Hepatotoxicity2▲ 30×2 topics
- Metal-Catalyzed Reactions2▲ 23×2 topics
- Genomic Profiling2▲ 20×2 topics
- Neurotoxicity2▲ 11×2 topics
- ALK Inhibitors2▲ 34×1 topic
- Chemotherapy-Induced Peripheral Neuropathy2▲ 37×1 topic
- EGFR Mutations2▲ 34×1 topic
- Taxanes2▲ 37×1 topic
Which research topics does Bristol-Myers Squibb (Canada) publish most on?
By volume in 2022–2025: Cardiomyopathy and Myosin Studies, Health Systems, Economic Evaluations, Quality of Life, Cardiovascular Function and Risk Factors and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 1 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 3 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 5 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 8 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 10 Primary Care and Health Outcomes General Health Professions 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bristol-Myers Squibb (Canada)'s research output changed?
Output in 2018–2022 was 18% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Montreal
- McGill University
- Université de Montréal
- Concordia University
- Université du Québec à Montréal
- Polytechnique Montréal
- McGill University Health Centre
- CAE (Canada)
- École de Technologie Supérieure
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.